A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 6011877
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity |
scientific article; zbMATH DE number 6011877 |
Statements
A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (English)
0 references
5 March 2012
0 references
Bayesian design
0 references
treatment selection
0 references
0 references
0 references
0.7742869853973389
0 references
0.7592912316322327
0 references
0.7465983629226685
0 references
0.7465983629226685
0 references
0.7365257740020752
0 references
